Other disclosed activity · SNTI
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Rajangam KanyaPres. & Chief Med. & Dev. Off. |  SNTISenti Biosciences Holdings, Inc.Tax withholding | F | — 20.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
Director, CEO · Senti Biosciences Holdings, Inc. · Common Stock
Tax withholding — administrative, little informational value
No reported dollar value · 48.4% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Rajangam KanyaPres. & Chief Med. & Dev. Off. | SNTISenti Biosciences Holdings, Inc. Tax withholding | F | — 20.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Lu Timothy K filed this Form 4 reporting a tax withholding of SNTI on Oct 21, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.